Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat.
| Autor: | Patel P; Infectious Disease, Mount Sinai Medical Center, Miami Beach, USA., Espinosa C; Internal Medicine, Mount Sinai Medical Center, Miami Beach, USA., Konyala V; Infectious Diseases, Mount Sinai Medical Center, Miami Beach, USA., Camps NS; Internal Medicine, Mount Sinai Medical Center, Miami Beach, USA., Cecilio E; Internal Medicine, Mount Sinai Medical Center, Miami Beach, USA., Jain A; Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA., Tuda C; Infectious Disease, Mount Sinai Medical Center, Miami Beach, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Mar 16; Vol. 15 (3), pp. e36238. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.36238 |
| Abstrakt: | Monkeypox (MPX) is an exanthematous disease first identified in the 1950s, associated with animals in Central and Western Africa, and has since been found sporadically worldwide. In May 2022, a returning family from Nigeria tested positive for MPX, which marked the onset of the current outbreak. It has now become a disease of concern in most parts of the world. The current standings are nearing 90,000 cases, with numbers increasing daily. The United States reported 29,711 cases so far. The characteristic exanthem of MPX is known to be present ubiquitously on the human habitus, with recent reports describing anogenital and mucosal lesions. Here, we present a rare case of a 43-year-old male presenting with excruciating perianal pain and purulent discharge, found to have proctitis secondary to MPX, and subsequently treated with Tecovirimat, a targeted antiviral therapy. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Patel et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|